Sign in

CIK 0001645469

  • Non-accelerated filer
  • Smaller reporting company

Monopar Therapeutics

Sign in to watch
Ticker
MNPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320463781
Phone
+1 847-388-0349
Business address
1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
  1. 4 Shares withheld for taxes Chief Operating Officer gave up 1,406 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 2,569 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Executive Officer gave up 7,141 shares (to pay taxes)
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy Chief Operating Officer bought 16,053 shares at an average $3.09 ($49,659)
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 1,753 shares (to pay taxes)
  7. 4 Option exercise Director acquired 2,859 shares (option exercise)
  8. 4 Shares withheld for taxes Chief Executive Officer gave up 4,077 shares (to pay taxes)
  9. 4 Option exercise Director acquired 2,859 shares (option exercise)
  10. 4 Shares withheld for taxes Chief Operating Officer gave up 1,191 shares (to pay taxes)
  11. 4 Option exercise Director acquired 2,859 shares (option exercise)
  12. 4 Option exercise Director acquired 2,859 shares (option exercise)
  13. 4 Option exercise Director acquired 2,859 shares (option exercise)
  14. 4 Shares withheld for taxes Chief Operating Officer gave up 2,812 shares (to pay taxes)
  15. 4 Option exercise Director acquired 2,859 shares (option exercise)
  16. 4 Option exercise Director acquired 2,859 shares (option exercise)
  17. 4 Shares withheld for taxes Chief Executive Officer gave up 6,999 shares (to pay taxes)
  18. 4 Option exercise Director acquired 2,859 shares (option exercise)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 3,083 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Executive Officer gave up 1,155 shares (to pay taxes)

Page 7 of 13 · 247 filings